Clinical research of hypertension and arteriosclerotic disease in Chaoshan region, China

Clinical research of hypertension and arteriosclerotic disease in Chaoshan region, China

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IOR-15006682

Enrollment

Unknown

Registered

2015-06-24

Start date

2015-07-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension and arteriosclerotic disease

Interventions

1:Losartan / hydrochlorothiazide hydrogen

2:Valsartan/ hydrochlorothiazide hydrogen

3:Amlodipine/Valsartan

4:Irbesartan

5:Nifedipine

6:Amlodipine

Sponsors

First Affiliated Hospital of Shantou University Medical College

Lead Sponsor

Eligibility

Sex/Gender

All

Age

36 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of hypertension: 1. Systolic BP (SBP) >=140 mm Hg or diastolic BP (DBP) >=90 mm Hg; 2. Self-reported treatment of hypertension with antihypertensive medication or history of hypertension.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria of hypertension:Secondary hypertension.

Design outcomes

Primary

Measure	Time frame
Resting blood pressure;12-lead electrocardiography;Plasma glucose;Lipid profile;alanine aminotransferase;aspartate transaminase;creatinine;uricacid;	—

Contacts

Public ContactHongxing Pan

pan_hongxing@163.com+86 0754-88905620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026